Prognostic value of PD-L1 and PD-1 expression in upper tract urothelial carcinoma patients.

Luca CampedelEva CompératGeraldine Cancel-TassinJustine VarinotChristian PfisterClara DelcourtFrançoise GobetMathieu RoumiguiéPierre-Marie PatardGwendoline DanielPierre BigotJulie CarrougetCaroline EymeritStéphane LarréPriscilla LeonAnne DurlachAlain RuffionEmilien Seizilles de MazancourtMyriam Decaussin-PetrucciThomas BessèdeCedric LebacleSophie FerlicotGrégoire RobertNam-Son VuongMagali PhilipSébastien CrouzetXavier MatillonFlorence Mège-LechevallierHervé LangPascal MouracadeVéronique LindnerPaul GougisOlivier CussenotMorgan RouprêtThomas Seisen

Published in: BJU international (2023)

We observed that PD-L1 and PD-1 expression were both associated with adverse pathological features that translated into an independent and cumulative adverse prognostic value in UTUC patients treated with RNU.

Keyphrases

poor prognosis
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
binding protein
prognostic factors
adverse drug